Anne Husebekk
Corporate Officer/Principal chez University of Tromso
Profil
Anne Husebekk is the founder of Prophylix AS, which was founded in 2008.
She held the title of Chief Operating Officer & Project Developer.
Currently, she is a Professor & Dean-Scientific Affairs at the University of Tromso.
Dr. Husebekk earned a doctorate degree from the University of Tromso.
Postes actifs de Anne Husebekk
| Sociétés | Poste | Début |
|---|---|---|
| University of Tromso | Corporate Officer/Principal | - |
Anciens postes connus de Anne Husebekk
| Sociétés | Poste | Fin |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Fondateur | - |
Formation de Anne Husebekk
| University of Tromso | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
